These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19461040)
1. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Kasner SE Stroke; 2009 Jul; 40(7):2332-6. PubMed ID: 19461040 [TBL] [Abstract][Full Text] [Related]
2. D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification. Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Pollak ES; Kasner SE J Stroke Cerebrovasc Dis; 2009; 18(5):367-73. PubMed ID: 19717021 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients. Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747 [TBL] [Abstract][Full Text] [Related]
4. Blood C-reactive protein concentration with ABCD² is a better prognostic tool than ABCD² alone. Corso G; Bottacchi E; Brusa A; Lia C; Cordera S; Giardini G; Pesenti Campagnoni M; Veronese Morosini M Cerebrovasc Dis; 2011; 32(2):97-105. PubMed ID: 21709407 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women. Wassertheil-Smoller S; Kooperberg C; McGinn AP; Kaplan RC; Hsia J; Hendrix SL; Manson JE; Berger JS; Kuller LH; Allison MA; Baird AE Hypertension; 2008 Apr; 51(4):1115-22. PubMed ID: 18259035 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2 predicts 5-year cardiac mortality independently of established risk factors and adds prognostic information in patients with low and medium high-sensitivity C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Winkler K; Hoffmann MM; Winkelmann BR; Friedrich I; Schäfer G; Seelhorst U; Wellnitz B; Wieland H; Boehm BO; März W Clin Chem; 2007 Aug; 53(8):1440-7. PubMed ID: 17573419 [TBL] [Abstract][Full Text] [Related]
7. Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores. Purroy F; Jiménez Caballero PE; Gorospe A; Torres MJ; Alvarez-Sabin J; Santamarina E; Martínez-Sánchez P; Cánovas D; Freijo MM; Egido JA; Girón JM; Ramírez-Moreno JM; Alonso A; Rodríguez-Campello A; Casado I; Delgado-Medeiros R; Martí-Fàbregas J; Fuentes B; Silva Y; Quesada H; Cardona P; Morales A; de la Ossa N; García-Pastor A; Arenillas JF; Segura T; Jiménez C; Masjuán J; Cerebrovasc Dis; 2012; 33(2):182-9. PubMed ID: 22237056 [TBL] [Abstract][Full Text] [Related]
8. Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Cucchiara BL; Messe SR; Taylor RA; Pacelli J; Maus D; Shah Q; Kasner SE Stroke; 2006 Jul; 37(7):1710-4. PubMed ID: 16763186 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein phospholipase A2 mass and activity are not associated with the diagnosis of acute brain ischemia. Tai W; Garcia M; Mlynash M; Kemp S; Albers GW; Olivot JM Cerebrovasc Dis; 2014; 38(5):324-7. PubMed ID: 25428761 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Arenillas JF; Alvarez-Sabín J; Molina CA; Chacón P; Montaner J; Rovira A; Ibarra B; Quintana M Stroke; 2003 Oct; 34(10):2463-8. PubMed ID: 14500938 [TBL] [Abstract][Full Text] [Related]
11. Population-based study of ABCD2 score, carotid stenosis, and atrial fibrillation for early stroke prediction after transient ischemic attack: the North Dublin TIA study. Sheehan OC; Kyne L; Kelly LA; Hannon N; Marnane M; Merwick A; McCormack PM; Duggan J; Moore A; Moroney J; Daly L; Harris D; Horgan G; Williams EB; Kelly PJ Stroke; 2010 May; 41(5):844-50. PubMed ID: 20299667 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lipoprotein-associated phospholipase A Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J; Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604 [TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease. Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J; Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330 [TBL] [Abstract][Full Text] [Related]
14. DWI lesions and TIA etiology improve the prediction of stroke after TIA. Calvet D; Touzé E; Oppenheim C; Turc G; Meder JF; Mas JL Stroke; 2009 Jan; 40(1):187-92. PubMed ID: 18988917 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic usefulness of the ABCD2 score to distinguish transient ischemic attack and minor ischemic stroke from noncerebrovascular events: the North Dublin TIA Study. Sheehan OC; Merwick A; Kelly LA; Hannon N; Marnane M; Kyne L; McCormack PM; Duggan J; Moore A; Moroney J; Daly L; Harris D; Horgan G; Kelly PJ Stroke; 2009 Nov; 40(11):3449-54. PubMed ID: 19745173 [TBL] [Abstract][Full Text] [Related]
16. Validation of the ABCD score in identifying individuals at high early risk of stroke after a transient ischemic attack: a hospital-based case series study. Tsivgoulis G; Spengos K; Manta P; Karandreas N; Zambelis T; Zakopoulos N; Vassilopoulos D Stroke; 2006 Dec; 37(12):2892-7. PubMed ID: 17053179 [TBL] [Abstract][Full Text] [Related]
17. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke. Lin J; Zheng H; Cucchiara BL; Li J; Zhao X; Liang X; Wang C; Li H; Mullen MT; Johnston SC; Wang Y; Wang Y; Neurology; 2015 Nov; 85(18):1585-91. PubMed ID: 26311748 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 and risk of stroke. Gorelick PB Am J Cardiol; 2008 Jun; 101(12A):34F-40F. PubMed ID: 18549870 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up. Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783 [TBL] [Abstract][Full Text] [Related]
20. Link between lipoprotein-associated phospholipase A2 gene expression of peripheral-blood mononuclear cells and prognostic outcome after acute ischemic stroke. Tsai TH; Chen YL; Lin HS; Liu CF; Chang HW; Lu CH; Chang WN; Chen SF; Wu CJ; Leu S; Ko SF; Yip HK J Atheroscler Thromb; 2012; 19(6):523-31. PubMed ID: 22447189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]